What changed in Tonix Pharmaceuticals Holding Corp.'s 2025 10-K compared to 2024?

Across the narrative sections we track, Tonix Pharmaceuticals Holding Corp. (TNXP) added 0 paragraphs, removed 0, and edited 0 between the 2024 and 2025 10-K filings. The biggest movers are .

Where does this TNXP 10-K diff come from?

The source filings are Tonix Pharmaceuticals Holding Corp.'s official 2024 and 2025 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

Tonix Pharmaceuticals Holding Corp.TNXPEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep Analysis

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

What changed in Tonix Pharmaceuticals Holding Corp.'s 10-K — 2024 vs 2025

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other TNXP 10-K year-over-year comparisons

TNXP 10-K 2023 vs 2024